Literature DB >> 8530587

Expression of functional growth hormone receptors in cultured human osteoblast-like cells.

A Nilsson1, D Swolin, S Enerback, C Ohlsson.   

Abstract

Recent clinical studies indicate that GH is important for bone remodeling. Patients with GH deficiency exhibit decreased bone density, and GH substitution increases bone density in these patients. The aim of the present study was to investigate the presence of GH receptors and the effects of GH on cultured human osteoblast-like cells. Primary cultures of human osteoblast-like cells were established from trabecular bone. Northern blot analysis, using a probe recognizing exon 10 of the human GH receptor, revealed a 4.7-kilobase transcript corresponding to the human GH receptor. Cultured osteoblast-like cells expressed, as determined by RNase protection assay, approximately one fourth of the GH receptor messenger RNA levels found in liver. Binding studies using 125I-labeled GH revealed a single class of receptors with approximately 2000 binding sites per cell and an association constant (Ka) of 2.6 x 10(9) M-1. GH stimulation of the cultured cells resulted in increased [3H]thymidine incorporation, suggesting that the GH receptors are functional. In summary, the present study shows that cultured human osteoblast-like cells express functional GH receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530587     DOI: 10.1210/jcem.80.12.8530587

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

Review 3.  The interrelationship between bone and fat: from cellular see-saw to endocrine reciprocity.

Authors:  H Sadie-Van Gijsen; N J Crowther; F S Hough; W F Ferris
Journal:  Cell Mol Life Sci       Date:  2012-11-21       Impact factor: 9.261

Review 4.  Regulation of skeletal growth and mineral acquisition by the GH/IGF-1 axis: Lessons from mouse models.

Authors:  Shoshana Yakar; Olle Isaksson
Journal:  Growth Horm IGF Res       Date:  2015-09-28       Impact factor: 2.372

5.  Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.

Authors:  Yujun Gan; Yue Zhang; Douglas J Digirolamo; Jing Jiang; Xiangdong Wang; Xuemei Cao; Kurt R Zinn; David P Carbone; Thomas L Clemens; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2010-02-04

6.  Effects of alcohol on skeletal response to growth hormone in hypophysectomized rats.

Authors:  Russell T Turner; Clifford J Rosen; Urszula T Iwaniec
Journal:  Bone       Date:  2009-10-30       Impact factor: 4.398

Review 7.  Growth hormone, insulin-like growth factors, and the skeleton.

Authors:  Andrea Giustina; Gherardo Mazziotti; Ernesto Canalis
Journal:  Endocr Rev       Date:  2008-04-24       Impact factor: 19.871

Review 8.  Effects of growth hormone and its secretagogues on bone.

Authors:  J Svensson; S Lall; S L Dickson; B A Bengtsson; J Rømer; I Ahnfelt-Rønne; C Ohlsson; J O Jansson
Journal:  Endocrine       Date:  2001-02       Impact factor: 3.925

Review 9.  Effects of growth hormone on body composition and bone metabolism.

Authors:  A L Carrel; D B Allen
Journal:  Endocrine       Date:  2000-04       Impact factor: 3.925

10.  MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs.

Authors:  Youn Hee Joung; Eun Joung Lim; Pramod Darvin; So Chung Chung; Ju Woong Jang; Kyung Do Park; Hak Kyo Lee; Heui Soo Kim; Taekyu Park; Young Mok Yang
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.